Calpain, Small Subunit 2 (CAPNS2) (N-Term) Peptid
CAPNS2
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN974450
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Calpain, Small Subunit 2 (CAPNS2) (N-Term) Peptid (ABIN974450)
Target
CAPNS2
(Calpain, Small Subunit 2 (CAPNS2))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- GRNIGGIVGG IVNFISEAAA AQYTPEPPPT QQHFTSVEAS ESEEVRRFRQ
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-CAPNS2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CAPNS2 (Calpain, Small Subunit 2 (CAPNS2))
-
Hintergrund
-
CAPNS2 is a calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. This small subunit may act as a tissue-specific chaperone of the large subunit, possibly by helping it fold into its correct conformation for activity.
Alias Symbols: MGC12536, MGC14804
Protein Interaction Partner: CAPN2
Protein Size: 248 -
Molekulargewicht
- 28 kDa
-
Gen-ID
- 84290
-
NCBI Accession
- NM_032330, NP_115706
-
UniProt
- Q96L46
Target
-
Sie sind hier:
